Iambic CEO joins AI drug discovery panel at Jefferies conference
IAM•Iambic CEO Tom Miller will attend the Jefferies Global Healthcare Conference in London from Nov. 16-19, 2026, and join a panel on AI in drug discovery on Nov. 18 at 2:00 p.m. GMT.
1. Conference appearance
Tom Miller will participate in a panel on AI in drug discovery at the Jefferies Global Healthcare Conference in London on Nov. 18 at 2:00 p.m. GMT. The conference runs from Nov. 16-19, 2026.
